| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/27/2009 | WO2009086439A3 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2009086438A3 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 08/27/2009 | WO2007044069A3 Pth formulations and methods of use |
| 08/27/2009 | US20090216336 Bioresorbable, mineralised material for filling osseous defects |
| 08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
| 08/27/2009 | US20090215850 Method for treating cb2 receptor mediated pain |
| 08/27/2009 | US20090215809 crystalline calcium (3S)-{[(1R)-isobutanoyloxyethoxy]carbonylaminomethyl}-5-methyl-hexanoate hydrate; sustained release oral dosage formualtion with opioid agonist, selective serotonin re-uptake inhibitor and noradrenaline re-uptake inhibitor; an inflammatory disease, neuropathic pain, anxiety, psychosis |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215776 Organic compounds |
| 08/27/2009 | US20090215746 Substituted pyrazolo[1,5-a]pyrimidines as calcium receptor modulating agents |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090215707 Compound having cyclic structure and use thereof |
| 08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
| 08/27/2009 | US20090214649 Scaffolds with oxygen carriers, and their use in tissue regeneration |
| 08/27/2009 | US20090214573 Modulation of bne development |
| 08/27/2009 | US20090214500 Prevention and treatment of osteochondrosis in animals and humans |
| 08/27/2009 | CA2715771A1 Adrenomedullin production enhancer |
| 08/27/2009 | CA2715486A1 Composition for modulating stem cell growth with prostaglandins |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093214A1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 08/26/2009 | EP2092940A1 Herbal medicine for osteoporosis and related conditions |
| 08/26/2009 | EP2091952A1 Pyrazolo ý3, 4 -d¨pyrimidine p38 map kinase inhibitors |
| 08/26/2009 | EP2091544A2 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 08/26/2009 | EP2091540A1 Pyrazolyl derivatives with analgesic activity and therefore useful in the treatment or prophylaxis of pain. |
| 08/26/2009 | EP2026821B1 Hyaluronic acid binary mixtures and therapeutic use thereof |
| 08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |
| 08/26/2009 | EP1485087B1 (+)-2- [1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione for use in treating psoriasis by oral administration |
| 08/26/2009 | EP1478328A4 Bioactive keratin peptides |
| 08/26/2009 | EP1423428B1 Antibodies that block fgfr3 activation, methods of screening for and uses thereof |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | CN101516888A Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 08/26/2009 | CN101516881A 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 08/26/2009 | CN101516400A Therapeutic agent for acceleration of spinal nerve repair comprising ghrelin, derivative thereof or substance capable of acting on GHS-R1a as active ingredient |
| 08/26/2009 | CN101516386A Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 08/26/2009 | CN101516385A Treatment of excessive neovascularization |
| 08/26/2009 | CN101516364A Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 08/26/2009 | CN101516363A Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of cartilage degradation or cartilage damage in joints |
| 08/26/2009 | CN101514232A RANKL-Fc fusion protein, preparation method and application thereof |
| 08/26/2009 | CN101513522A Chinese medical herbs aerosols for treating anchylosis, painful swelling and preparation method thereof |
| 08/26/2009 | CN101513499A Chinese medicinal composition for promoting fracture healing |
| 08/26/2009 | CN101513484A A medicament composition for preventing and treating osteoporosis and the preparation thereof |
| 08/26/2009 | CN101513483A Rhizoma cibotii and eucommia bark soup used for curing protrusion of lumbar intervertebral disc |
| 08/26/2009 | CN101513473A Composition capable of bidirectionally adjusting bone mineral density and restoring bone joints and preparation method thereof |
| 08/26/2009 | CN101513470A Chinese patent medicine for treating cervical vertebra disease |
| 08/26/2009 | CN101513469A Chinese medicinal composition for resisting rheumatoid arthritis, and preparation method thereof |
| 08/26/2009 | CN101513452A Decumbent corydalis tuber cataplasm and preparation method thereof |
| 08/26/2009 | CN101513446A Oral medicament for treating traumatic injury and production method thereof |
| 08/26/2009 | CN101513427A Use of epimedin C |
| 08/26/2009 | CN101513399A Application of T-2 toxin in the preparation of drugs for treating bone cancers and myeloproliferative disorder |
| 08/26/2009 | CN101513388A Icariin microemulsion and preparation method thereof |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/26/2009 | CN100531789C Chinese medicine for treating injury |
| 08/26/2009 | CN100531782C A Chinese medicinal composition for treating lumbar intervertebral protrusion |
| 08/26/2009 | CN100531779C Medicinal ointment for treating hyperosteogeny, anemofrigid-damp arthralgia, strain and sprain and preparation method thereof |
| 08/26/2009 | CN100531758C Composition for treating gout |
| 08/26/2009 | CN100531756C Externally used Chinese traditional medicine for treating osteopathy |
| 08/26/2009 | CN100531739C Use of carbon-2-modified-19-nor-vitamin D analogs to induce the formation of new bone |
| 08/26/2009 | CN100531731C Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the preparation of composition for the treatment of osteoporosis |
| 08/26/2009 | CN100531710C Alendronate pharmaceutical composition and its preparation technique |
| 08/25/2009 | US7579494 Prevention of neutrophil recruitment |
| 08/25/2009 | US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia |
| 08/25/2009 | US7579466 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579435 Somatostatin-dopamine chimeric analogs |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579374 Using fatty esters |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | US7579166 lysosomal enzyme having a mannose-6-phosphate-containing acidic sugar chain; a labeling marker for transporting into lysosomes; used as a drug effective in treatment of human lysosomal enzyme deficiencies |
| 08/25/2009 | CA2439078C Composition improving age-related physiological deficits and increasing longevity |
| 08/25/2009 | CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/25/2009 | CA2269246C Substituted tricyclics |
| 08/25/2009 | CA2234500C Novel biologically active silicon-based compositions |
| 08/25/2009 | CA2099541C Cyclic adhesion inhibitors |
| 08/20/2009 | WO2009102789A2 Use of rxr agonists for the treatment of osteroarthritis |
| 08/20/2009 | WO2009102773A1 Methods of preparing polymorphic form a of bazedoxifene acetate |
| 08/20/2009 | WO2009101856A1 Remedy for rheumatoid arthritis |
| 08/20/2009 | WO2009101467A1 Formulation and method for the prevention and treatment of skeletal manifestation of gaucher's disease |
| 08/20/2009 | WO2009101210A1 Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases |
| 08/20/2009 | WO2009101194A1 Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases |
| 08/20/2009 | WO2009101135A1 Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporosis |
| 08/20/2009 | WO2009034452A4 Compound and device for treating bone and/or cartilage defects |
| 08/20/2009 | WO2009033789A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2008148873A3 Hydroxyproline compositions and uses thereof |
| 08/20/2009 | WO2008069348A9 Pharmaceutical agent having long-lasting effect of treating arthritic disorders |
| 08/20/2009 | US20090209747 Method to inhibit cell growth using oligonucleotides |
| 08/20/2009 | US20090209648 Phenylacetic Acid Derivatives |
| 08/20/2009 | US20090209624 Compositions and their uses for gene therapy of bone conditions |
| 08/20/2009 | US20090209601 Use of rxr agonists for the treatment of osteoarthritis |
| 08/20/2009 | US20090209595 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209594 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209577 Novel Triazolopyridine Compounds |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209521 Inhibition of VEGF Translation |
| 08/20/2009 | US20090209468 Alpha-neurotoxin proteins with anti-inflammatory properties and uses thereof |